Literature DB >> 20626460

Disruption of morphine-conditioned place preference by a delta2-opioid receptor antagonist: study of mu-opioid and delta-opioid receptor expression at the synapse.

Sophie K Billa1, Yan Xia, Jose A Morón.   

Abstract

The addictive properties of morphine limit its clinical use. Learned associations that develop between the abused opiate and the environment in which it is consumed are engendered through Pavlovian conditioning processes. Disruption of the learned associations between the opiate and environmental cues may be a therapeutic approach to prevent morphine dependence. Although a role for the delta-opioid receptor in the regulation of the rewarding properties of morphine has already been shown, in this study we further characterized the role of the delta-opioid receptor in morphine-induced conditioned responses by examining the effect of a selective delta2-opioid receptor antagonist (naltriben), using a conditioned place preference paradigm in rats. Additionally, we used a subcellular fractionation technique to analyze the synaptic localization of mu-opioid and delta-opioid receptors in the hippocampus, in order to examine the molecular mechanisms that may underlie this morphine-induced conditioned behavior. Our data show that the administration of 1 mg/kg naltriben (but not 0.1 mg/kg) prior to morphine was able to block morphine-induced conditioned place preference. Interestingly, this naltriben-induced disruption of morphine conditioned place preference was associated with a significant increase in the expression of the delta-opioid receptor dimer at the postsynaptic density. In addition, we also observed that morphine conditioned place preference was associated with an increase in the expression of the mu-opoid receptor in the total homogenate. Overall, these results suggest that modulation of the delta-opioid receptor expression and its synaptic localization may constitute a viable therapeutic approach to disrupt morphine-induced conditioned responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20626460      PMCID: PMC3596814          DOI: 10.1111/j.1460-9568.2010.07314.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  37 in total

1.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

Authors:  S R George; T Fan; Z Xie; R Tse; V Tam; G Varghese; B F O'Dowd
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

Review 2.  Regulations of opioid dependence by opioid receptor types.

Authors:  M Narita; M Funada; T Suzuki
Journal:  Pharmacol Ther       Date:  2001-01       Impact factor: 12.310

3.  Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

4.  Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.

Authors:  C M Cahill; A Morinville; M C Lee; J P Vincent; B Collier; A Beaudet
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  Dorsal/ventral hippocampus, fornix, and conditioned place preference.

Authors:  J Ferbinteanu; R J McDonald
Journal:  Hippocampus       Date:  2001       Impact factor: 3.899

6.  Chronic morphine-induced changes in mu-opioid receptors and G proteins of different subcellular loci in rat brain.

Authors:  G Fábián; B Bozó; M Szikszay; G Horváth; C J Coscia; M Szücs
Journal:  J Pharmacol Exp Ther       Date:  2002-08       Impact factor: 4.030

Review 7.  Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.

Authors:  T S Shippenberg; A LeFevour; V I Chefer
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-11       Impact factor: 4.388

8.  Conditioned place preference produced by intra-hippocampal morphine.

Authors:  W A Corrigall; M A Linseman
Journal:  Pharmacol Biochem Behav       Date:  1988-07       Impact factor: 3.533

Review 9.  Apparatus bias and place conditioning with ethanol in mice.

Authors:  Christopher L Cunningham; Nikole K Ferree; MacKenzie A Howard
Journal:  Psychopharmacology (Berl)       Date:  2003-10-30       Impact factor: 4.530

Review 10.  Psychomotor stimulant addiction: a neural systems perspective.

Authors:  Barry J Everitt; Marina E Wolf
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

View more
  18 in total

1.  Differential modulation of drug-induced structural and functional plasticity of dendritic spines.

Authors:  Eric C Miller; Lei Zhang; Benjamin W Dummer; Desmond R Cariveau; Horace Loh; Ping-Yee Law; Dezhi Liao
Journal:  Mol Pharmacol       Date:  2012-05-17       Impact factor: 4.436

2.  Neuroplasticity transcript profile of the ventral striatum in the extinction of opioid-induced conditioned place preference.

Authors:  Freddyson J Martínez-Rivera; Namyr A Martínez; Magdiel Martínez; Roxsana N Ayala-Pagán; Walter I Silva; Jennifer L Barreto-Estrada
Journal:  Neurobiol Learn Mem       Date:  2019-06-04       Impact factor: 2.877

3.  Opioid receptor-dependent sex differences in synaptic plasticity in the hippocampal mossy fiber pathway of the adult rat.

Authors:  Lauren C Harte-Hargrove; Ada Varga-Wesson; Aine M Duffy; Teresa A Milner; Helen E Scharfman
Journal:  J Neurosci       Date:  2015-01-28       Impact factor: 6.167

4.  Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.

Authors:  H Beaudry; L Gendron; J A Morón
Journal:  Eur J Neurosci       Date:  2015-01-09       Impact factor: 3.386

Review 5.  Recent advances on the δ opioid receptor: from trafficking to function.

Authors:  Louis Gendron; Nitish Mittal; Hélène Beaudry; Wendy Walwyn
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 6.  Novel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.

Authors:  Chris P Bailey; Stephen M Husbands
Journal:  Expert Opin Drug Discov       Date:  2014-09-25       Impact factor: 6.098

Review 7.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 8.  Sex differences in hippocampal area CA3 pyramidal cells.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 9.  Functional relevance of μ-δ opioid receptor heteromerization: a role in novel signaling and implications for the treatment of addiction disorders: from a symposium on new concepts in mu-opioid pharmacology.

Authors:  Steven D Stockton; Lakshmi A Devi
Journal:  Drug Alcohol Depend       Date:  2011-11-23       Impact factor: 4.492

Review 10.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.